{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-vaccine-ip-accountability-and-wastage-spillage”
},
“headline”: “SOP for Vaccine IP Accountability and Wastage/Spillage”,
“description”: “This SOP establishes procedures for accountability, reconciliation, and handling of wastage and spillage of investigational vaccines (IP) during clinical trials. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements for vaccine storage, use, accountability, and destruction.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Vaccine IP Accountability and Wastage/Spillage

Purpose

The purpose of this SOP is to define standardized procedures for accountability and reconciliation of investigational vaccines (IP) used in clinical trials, as well as to describe actions for handling wastage and spillage. These procedures safeguard trial integrity, ensure accurate dosing records, and maintain regulatory compliance.

Scope

This SOP applies to sponsors, investigators, pharmacists, CROs, and site staff involved in vaccine clinical trials. It covers accountability records, wastage management, spillage handling, destruction, return processes, and documentation at all trial stages.

Responsibilities

• Sponsor: Ensures adequate systems for IP accountability and oversees reconciliation.
• Investigator: Maintains accurate accountability logs and ensures prompt reporting of wastage/spillage.
• Pharmacist/Site Staff: Document vaccine receipt, use, wastage, destruction, or return.
• CRO: Verifies accountability records and monitors wastage reports.
• QA: Reviews accountability logs and ensures compliance with GCP and GMP.

Accountability

The Investigator is accountable for IP accountability, wastage, and spillage records at the site. The Sponsor is accountable for overall oversight and reconciliation of vaccine IP across sites.

Procedure

1. Vaccine IP Receipt and Storage
1.1 Record all vaccine IP received in Vaccine Receipt Log.
1.2 Store in validated storage with continuous temperature monitoring.
1.3 Document in Vaccine Storage Log.

2. IP Accountability
2.1 Record doses received, dispensed, administered, returned, destroyed, or wasted.
2.2 Reconcile balances weekly and at study closeout.
2.3 Maintain Vaccine Accountability Log (Annexure-1).

3. Wastage Management
3.1 Document reasons for wastage (e.g., expired, broken vials, temperature excursion).
3.2 Record in Wastage Log (Annexure-2).
3.3 Notify Sponsor and QA.

4. Spillage Handling
4.1 Contain spill immediately using PPE and absorbent materials.
4.2 Dispose waste as per biosafety and hazardous waste protocols.
4.3 Document incident in Spillage Log (Annexure-3).

5. Destruction or Return
5.1 Destroy unusable vaccine IP as per biosafety regulations with QA oversight.
5.2 Obtain Destruction Certificate (Annexure-4).
5.3 Return unused IP if required by sponsor.

6. Reconciliation
6.1 Conduct reconciliation at site closeout and sponsor level.
6.2 Ensure accountability records match physical inventory.

7. Archiving
7.1 Archive accountability, wastage, and spillage records in TMF and ISF.
7.2 Retain per regulatory requirements.

Abbreviations

• SOP: Standard Operating Procedure
• IP: Investigational Product
• QA: Quality Assurance
• CRO: Contract Research Organization
• TMF: Trial Master File
• ISF: Investigator Site File
• GCP: Good Clinical Practice
• GMP: Good Manufacturing Practice
• PPE: Personal Protective Equipment

Documents

1. Vaccine Accountability Log (Annexure-1)
2. Wastage Log (Annexure-2)
3. Spillage Log (Annexure-3)
4. Destruction Certificate (Annexure-4)

References

• FDA – Vaccine Accountability Guidance
• EMA – Vaccine Accountability Guidelines
• CDSCO – Vaccine Accountability Rules
• ICH GCP – IP Accountability
• WHO – Vaccine Wastage and Spillage Handling

Version: 1.0

Approval Section

Annexures

Annexure-1: Vaccine Accountability Log

Annexure-2: Wastage Log

Annexure-3: Spillage Log

Annexure-4: Destruction Certificate

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-vaccine-trial-cold-chain-management-mass-trials”
},
“headline”: “SOP for Vaccine Trial Cold-Chain Management (Mass Trials)”,
“description”: “This SOP defines standardized procedures for cold-chain management in vaccine clinical trials, particularly mass vaccination trials. It ensures compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements, covering receipt, storage, transport, monitoring, accountability, and deviation handling of vaccines.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Vaccine Trial Cold-Chain Management (Mass Trials)

Purpose

The purpose of this SOP is to establish standardized procedures for cold-chain management of vaccines in clinical trials, with a focus on large-scale and mass vaccination trials. Proper cold-chain practices ensure product stability, subject safety, and compliance with international regulatory requirements.

Scope

This SOP applies to sponsors, CROs, investigators, site pharmacists, couriers, and laboratory staff involved in the receipt, storage, transport, and distribution of vaccines used in clinical trials. It covers cold-chain monitoring, accountability, excursion management, multi-site logistics, and regulatory compliance.

Responsibilities

• Sponsor: Ensures validated cold-chain systems are in place and audits compliance.
• Investigator: Oversees vaccine receipt, storage, and distribution at site level.
• Pharmacist/Site Staff: Responsible for storage, monitoring, accountability, and reporting deviations.
• CRO: Monitors adherence to cold-chain requirements across sites.
• Courier: Maintains validated shipping conditions during transport.
• QA: Audits cold-chain management and reviews deviation reports.

Accountability

The Sponsor’s Vaccine Supply Chain Lead is accountable for cold-chain compliance. The Investigator is accountable for site-level cold-chain management.

Procedure

1. Vaccine Receipt
1.1 Verify shipment condition, temperature monitors, and integrity upon arrival.
1.2 Document details in Vaccine Receipt Log (Annexure-1).
1.3 Report discrepancies immediately to sponsor and QA.

2. Storage
2.1 Store vaccines in validated refrigerators/freezers with continuous monitoring.
2.2 Maintain temperature ranges (e.g., +2°C to +8°C or per product label).
2.3 Document in Vaccine Storage Log (Annexure-2).

3. Distribution and Transport
3.1 Use validated shippers and cold-chain packaging.
3.2 Document distribution in Vaccine Distribution Log (Annexure-3).

4. Temperature Monitoring
4.1 Use calibrated data loggers with alarms.
4.2 Review temperature records daily.
4.3 Record in Temperature Monitoring Log (Annexure-4).

5. Excursion Management
5.1 Document all excursions in Excursion Log (Annexure-5).
5.2 Notify sponsor QA and regulatory authorities if excursions exceed thresholds.

6. Accountability
6.1 Reconcile doses received, used, destroyed, or returned.
6.2 Record in Vaccine Accountability Log (Annexure-6).

7. Multi-Site Logistics
7.1 Coordinate shipments across sites with validated logistics partners.
7.2 Document in Multi-Site Logistics Log (Annexure-7).

8. Archiving
8.1 Archive all cold-chain records in TMF and ISF.
8.2 Retain records per regulatory requirements.

Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• CRO: Contract Research Organization
• TMF: Trial Master File
• ISF: Investigator Site File
• GCP: Good Clinical Practice
• FDA: Food and Drug Administration
• EMA: European Medicines Agency
• CDSCO: Central Drugs Standard Control Organization
• WHO: World Health Organization

Documents

1. Vaccine Receipt Log (Annexure-1)
2. Vaccine Storage Log (Annexure-2)
3. Vaccine Distribution Log (Annexure-3)
4. Temperature Monitoring Log (Annexure-4)
5. Excursion Log (Annexure-5)
6. Vaccine Accountability Log (Annexure-6)
7. Multi-Site Logistics Log (Annexure-7)

References

• FDA – Vaccine Trial Guidelines
• EMA – Vaccine Storage & Transport Guidance
• CDSCO – Vaccine Cold-Chain Rules
• ICH GCP – Cold Chain and Vaccine Trials
• WHO – Cold Chain and Immunization Guidelines

Version: 1.0

Approval Section

Annexures

Annexure-1: Vaccine Receipt Log

Annexure-2: Vaccine Storage Log

Annexure-3: Vaccine Distribution Log

Annexure-4: Temperature Monitoring Log

Annexure-5: Excursion Log

Annexure-6: Vaccine Accountability Log

Annexure-7: Multi-Site Logistics Log

Revision History

For more SOPs visit: Pharma SOP